Neal James R

SEC Form 4 insider trading activity

Neal James R has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.

On the most recent filing, Neal James R is listed as Director at Processa Pharmaceuticals, Inc. Inside the rolling window, Neal James R reported 1 open-market purchase totaling $2K in PCSA and no open-market sales.

Companies traded

Other insiders at PCSA

Insider Buying

$2K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PCSA
Neal James R
Purchase$2KApr 2SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Neal James R made?

Neal James R has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.

Which companies does Neal James R trade?

Neal James R has filed SEC Form 4 disclosures for 1 company, including PCSA.

When was Neal James R's most recent SEC Form 4 filing?

Neal James R's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.

What is Neal James R's total buy and sell value in the current window?

Inside the rolling retention window, Neal James R bought $2K and sold $0 based on SEC Form 4 filings.

What was Neal James R's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 789 PCSA shares on 2026-03-31, worth $2K, per SEC Form 4 filings.